Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Sildenafil normalizes MALAT1 level in diabetic cardiomyopathy.

Bacci L, Barbati SA, Colussi C, Aiello A, Isidori AM, Grassi C, Pontecorvi A, Farsetti A, Gaetano C, Nanni S.

Endocrine. 2018 Apr 24. doi: 10.1007/s12020-018-1599-z. [Epub ahead of print] No abstract available.

PMID:
29691810
2.

Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations.

Quinkler M, Ekman B, Zhang P, Isidori AM, Murray RD; EU-AIR Investigators.

Clin Endocrinol (Oxf). 2018 Apr 22. doi: 10.1111/cen.13609. [Epub ahead of print]

PMID:
29682773
3.

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.

Breccia M, Abruzzese E, Castagnetti F, Bonifacio M, Gangemi D, Sorà F, Iurlo A, Luciano L, Gozzini A, Gentile M, Bocchia M, Luzi D, Maggi A, Sgherza N, Isidori A, Crugnola M, Pregno P, Scortechini AR, Capodanno I, Pizzuti M, Foà R.

Ann Hematol. 2018 Apr 19. doi: 10.1007/s00277-018-3337-2. [Epub ahead of print]

PMID:
29675611
4.

Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.

Polverelli N, Palumbo GA, Binotto G, Abruzzese E, Benevolo G, Bergamaschi M, Tieghi A, Bonifacio M, Breccia M, Catani L, Tiribelli M, D'Adda M, Sgherza N, Isidori A, Cavazzini F, Martino B, Latagliata R, Crugnola M, Heidel F, Bosi C, Ibatici A, Soci F, Penna D, Scaffidi L, Aversa F, Lemoli RM, Vitolo U, Cuneo A, Russo D, Cavo M, Vianelli N, Palandri F.

Hematol Oncol. 2018 Apr 6. doi: 10.1002/hon.2509. [Epub ahead of print]

PMID:
29624703
5.

Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies.

Cozzolino A, Feola T, Simonelli I, Puliani G, Pozza C, Giannetta E, Gianfrilli D, Pasqualetti P, Lenzi A, Isidori AM.

J Clin Endocrinol Metab. 2018 Mar 23. doi: 10.1210/jc.2017-02566. [Epub ahead of print]

PMID:
29590371
6.

Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply.

Isidori AM, Hasenmajer V, Venneri MA.

Lancet Diabetes Endocrinol. 2018 Apr;6(4):270-271. doi: 10.1016/S2213-8587(18)30040-8. No abstract available.

PMID:
29571509
7.

Kitcre knock-in mice fail to fate-map cardiac stem cells.

Vicinanza C, Aquila I, Cianflone E, Scalise M, Marino F, Mancuso T, Fumagalli F, Giovannone ED, Cristiano F, Iaccino E, Marotta P, Torella A, Latini R, Agosti V, Veltri P, Urbanek K, Isidori AM, Saur D, Indolfi C, Nadal-Ginard B, Torella D.

Nature. 2018 Mar 21;555(7697):E1-E5. doi: 10.1038/nature25771. No abstract available.

PMID:
29565363
8.

Testosterone Replacement Therapy: for whom, when and how?

Tsametis CP, Isidori AM.

Metabolism. 2018 Mar 9. pii: S0026-0495(18)30073-8. doi: 10.1016/j.metabol.2018.03.007. [Epub ahead of print] Review.

PMID:
29530796
9.

CARDIOVASCULAR FEATURES OF POSSIBLE AUTONOMOUS CORTISOL SECRETION IN PATIENTS WITH ADRENAL INCIDENTALOMAS.

Sbardella E, Minnetti M, D'Aluisio D, Rizza L, Di Giorgio MR, Vinci F, Pofi R, Giannetta E, Venneri MA, Vestri A, Morelli S, Lenzi A, Isidori AM.

Eur J Endocrinol. 2018 Mar 6. pii: EJE-17-0986. doi: 10.1530/EJE-17-0986. [Epub ahead of print]

PMID:
29510982
10.

Critical role of Phosphodiesterase 2A in mouse congenital heart defects.

Assenza MR, Barbagallo F, Barrios F, Cornacchione M, Campolo F, Vivarelli E, Gianfrilli D, Auletta L, Soricelli A, Isidori AM, Lenzi A, Pellegrini M, Naro F.

Cardiovasc Res. 2018 Feb 2. doi: 10.1093/cvr/cvy030. [Epub ahead of print]

PMID:
29409032
11.

Charge Density Waves in Graphite: Towards the Magnetic Ultraquantum Limit.

Arnold F, Isidori A, Kampert E, Yager B, Eschrig M, Saunders J.

Phys Rev Lett. 2017 Sep 29;119(13):136601. doi: 10.1103/PhysRevLett.119.136601. Epub 2017 Sep 26.

PMID:
29341727
12.

Smoke, alcohol and drug addiction and male fertility.

Sansone A, Di Dato C, de Angelis C, Menafra D, Pozza C, Pivonello R, Isidori A, Gianfrilli D.

Reprod Biol Endocrinol. 2018 Jan 15;16(1):3. doi: 10.1186/s12958-018-0320-7. Review.

13.

USPIO-labeling in M1 and M2-polarized macrophages: An in vitro study using a clinical magnetic resonance scanner.

Zini C, Venneri MA, Miglietta S, Caruso D, Porta N, Isidori AM, Fiore D, Gianfrilli D, Petrozza V, Laghi A.

J Cell Physiol. 2018 Aug;233(8):5823-5828. doi: 10.1002/jcp.26360. Epub 2018 Feb 27.

PMID:
29230805
14.

Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.

Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, Sbardella E, Gianfrilli D, Pozza C, Pasqualetti P, Morrone S, Santoni A, Naro F, Colao A, Pivonello R, Lenzi A.

Lancet Diabetes Endocrinol. 2018 Mar;6(3):173-185. doi: 10.1016/S2213-8587(17)30398-4. Epub 2017 Dec 8.

PMID:
29229498
15.

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

Visani G, Loscocco F, Ruzzo A, Galimberti S, Graziano F, Voso MT, Giacomini E, Finelli C, Ciabatti E, Fabiani E, Barulli S, Volpe A, Magro D, Piccaluga P, Fuligni F, Vignetti M, Fazi P, Piciocchi A, Gabucci E, Rocchi M, Magnani M, Isidori A.

Pharmacogenomics J. 2017 Dec 5. doi: 10.1038/tpj.2017.48. [Epub ahead of print]

PMID:
29205204
16.

Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

Sbardella E, Isidori AM, Arnaldi G, Arosio M, Barone C, Benso A, Berardi R, Capasso G, Caprio M, Ceccato F, Corona G, Della Casa S, De Nicola L, Faustini-Fustini M, Fiaccadori E, Gesualdo L, Gori S, Lania A, Mantovani G, Menè P, Parenti G, Pinto C, Pivonello R, Razzore P, Regolisti G, Scaroni C, Trepiccione F, Lenzi A, Peri A; the: Fluid and Electrolyte Disorders Club of the Italian Society of Endocrinology; Italian Society of Nephrology; and Italian Association of Medical Oncology.

J Endocrinol Invest. 2018 Jan;41(1):3-19. doi: 10.1007/s40618-017-0776-x. Epub 2017 Nov 20. No abstract available.

PMID:
29152673
17.

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.

Galimberti S, Bucelli C, Arrigoni E, Baratè C, Grassi S, Ricci F, Guerrini F, Ciabatti E, Fava C, D'Avolio A, Fontanelli G, Cambrin GR, Isidori A, Loscocco F, Caocci G, Greco M, Bocchia M, Aprile L, Gozzini A, Scappini B, Cattaneo D, Scortechini AR, La Nasa G, Bosi A, Leoni P, Danesi R, Saglio G, Visani G, Cortelezzi A, Petrini M, Iurlo A, Di Paolo A.

Oncotarget. 2017 Sep 30;8(50):88021-88033. doi: 10.18632/oncotarget.21406. eCollection 2017 Oct 20.

18.

Deregulation of the growth hormone/insulin-like growth factor-1 axis in adults with cystic fibrosis.

Pascucci C, De Biase RV, Savi D, Quattrucci S, Isidori AM, Lubrano C, Gnessi L, Lenzi A.

J Endocrinol Invest. 2018 May;41(5):591-596. doi: 10.1007/s40618-017-0784-x. Epub 2017 Nov 2.

PMID:
29098662
19.

Model of Murine Ventricular Cardiac Tissue for In Vitro Kinematic-Dynamic Studies of Electromagnetic and β-Adrenergic Stimulation.

Fassina L, Cornacchione M, Pellegrini M, Mognaschi ME, Gimmelli R, Isidori AM, Lenzi A, Magenes G, Naro F.

J Healthc Eng. 2017;2017:4204085. doi: 10.1155/2017/4204085. Epub 2017 Aug 8.

20.

Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study.

Visani G, Ferrara F, Di Raimondo F, Loscocco F, Fuligni F, Paolini S, Zammit V, Spina E, Rocchi M, Visani A, Piccaluga PP, Isidori A.

Leuk Res. 2017 Nov;62:77-83. doi: 10.1016/j.leukres.2017.09.019. Epub 2017 Sep 25.

21.

Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH).

Bonomi M, Vezzoli V, Krausz C, Guizzardi F, Vezzani S, Simoni M, Bassi I, Duminuco P, Di Iorgi N, Giavoli C, Pizzocaro A, Russo G, Moro M, Fatti L, Ferlin A, Mazzanti L, Zatelli MC, Cannavò S, Isidori AM, Pincelli AI, Prodam F, Mancini A, Limone P, Tanda ML, Gaudino R, Salerno M, Francesca P, Maghnie M, Maggi M, Persani L; Italian Network on Central Hypogonadism.

Eur J Endocrinol. 2018 Jan;178(1):23-32. doi: 10.1530/EJE-17-0065. Epub 2017 Sep 7.

PMID:
28882981
22.

Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.

Manganaro L, Saldari M, Pozza C, Vinci V, Gianfrilli D, Greco E, Franco G, Sergi ME, Scialpi M, Catalano C, Isidori AM.

Eur Radiol. 2018 Feb;28(2):554-564. doi: 10.1007/s00330-017-5013-7. Epub 2017 Aug 30.

PMID:
28856410
23.

Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling.

Tripodo C, Burocchi A, Piccaluga PP, Chiodoni C, Portararo P, Cappetti B, Botti L, Gulino A, Isidori A, Liso A, Visani G, Martelli MP, Falini B, Pandolfi PP, Colombo MP, Sangaletti S.

Cancer Res. 2017 Jul 1;77(13):3685-3699. doi: 10.1158/0008-5472.CAN-17-1098. Epub 2017 May 23.

PMID:
28536276
24.

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study.

Palandri F, Tiribelli M, Benevolo G, Tieghi A, Cavazzini F, Breccia M, Bergamaschi M, Sgherza N, Polverelli N, Crugnola M, Isidori A, Binotto G, Heidel FH, Buccisano F, Martino B, Latagliata R, Spinsanti M, Kallenberg L, Palumbo GA, Abruzzese E, Scaffidi L, Cuneo A, Cavo M, Vianelli N, Bonifacio M.

Hematol Oncol. 2018 Feb;36(1):285-290. doi: 10.1002/hon.2429. Epub 2017 May 17.

PMID:
28512865
25.

Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.

Sbardella E, Cranston T, Isidori AM, Shine B, Pal A, Jafar-Mohammadi B, Sadler G, Mihai R, Grossman AB.

Endocrine. 2018 Jan;59(1):175-182. doi: 10.1007/s12020-017-1310-9. Epub 2017 May 5.

PMID:
28477304
26.

Profiling of selenium absorption and accumulation in healthy subjects after prolonged L-selenomethionine supplementation.

Di Dato C, Gianfrilli D, Greco E, Astolfi M, Canepari S, Lenzi A, Isidori AM, Giannetta E.

J Endocrinol Invest. 2017 Nov;40(11):1183-1190. doi: 10.1007/s40618-017-0663-5. Epub 2017 Apr 9.

PMID:
28393316
27.

Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia.

Barbati SA, Colussi C, Bacci L, Aiello A, Re A, Stigliano E, Isidori AM, Grassi C, Pontecorvi A, Farsetti A, Gaetano C, Nanni S.

Endocrinology. 2017 Jul 1;158(7):2391-2405. doi: 10.1210/en.2016-1960.

PMID:
28368536
28.

Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7.

Pofi R, Fiore D, De Gaetano R, Panio G, Gianfrilli D, Pozza C, Barbagallo F, Xiang YK, Giannakakis K, Morano S, Lenzi A, Naro F, Isidori AM, Venneri MA.

Sci Rep. 2017 Mar 15;7:44584. doi: 10.1038/srep44584.

29.

Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line.

Campolo F, Zevini A, Cardarelli S, Monaco L, Barbagallo F, Pellegrini M, Cornacchione M, Di Grazia A, De Arcangelis V, Gianfrilli D, Giorgi M, Lenzi A, Isidori AM, Naro F.

J Cell Physiol. 2018 Jan;233(1):325-337. doi: 10.1002/jcp.25880. Epub 2017 May 18.

PMID:
28247930
30.

Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report.

Giannetta E, Isidori AM, Durante C, Di Gioia C, Longo F, Tombolini V, Bulzonetti N, Graziadio C, Pofi R, Gianfrilli D, Verrienti A, Carletti R, Filetti S, Lenzi A, Baroli A.

Medicine (Baltimore). 2017 Feb;96(6):e5621. doi: 10.1097/MD.0000000000005621.

31.

Hypothyroidism and Nephrotic Syndrome: Why, When and How to Treat.

Mario FD, Pofi R, Gigante A, Rivoli L, Rosato E, Isidori AM, Cianci R, Barbano B.

Curr Vasc Pharmacol. 2017;15(5):398-403. doi: 10.2174/1570161115999170207114706.

PMID:
28176633
32.

Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition.

Sonneveld R, Hoenderop JG, Isidori AM, Henique C, Dijkman HB, Berden JH, Tharaux PL, van der Vlag J, Nijenhuis T.

J Am Soc Nephrol. 2017 May;28(5):1491-1505. doi: 10.1681/ASN.2015080885. Epub 2016 Nov 28.

PMID:
27895156
33.

Gender-related differences in pulmonary arterial hypertension targeted drugs administration.

Marra AM, Benjamin N, Eichstaedt C, Salzano A, Arcopinto M, Gargani L, D Alto M, Argiento P, Falsetti L, Di Giosia P, Isidori AM, Ferrara F, Bossone E, Cittadini A, Grünig E.

Pharmacol Res. 2016 Dec;114:103-109. doi: 10.1016/j.phrs.2016.10.018. Epub 2016 Oct 19. Review.

PMID:
27771466
34.

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia.

Visani G, Manti A, Valentini L, Canonico B, Loscocco F, Isidori A, Gabucci E, Gobbi P, Montanari S, Rocchi M, Papa S, Gatti AM.

Leuk Res. 2016 Nov;50:50-56. doi: 10.1016/j.leukres.2016.09.004. Epub 2016 Sep 3.

PMID:
27669365
35.

Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.

Salzano A, Marra AM, Ferrara F, Arcopinto M, Bobbio E, Valente P, Polizzi R, De Vincentiis C, Matarazzo M, Saldamarco L, Saccà F, Napoli R, Monti MG, D'Assante R, Isidori AM, Isgaard J, Ferrara N, Filardi PP, Perticone F, Vigorito C, Bossone E, Cittadini A; T.O.S.CA. investigators.

Int J Cardiol. 2016 Dec 15;225:1-3. doi: 10.1016/j.ijcard.2016.09.085. Epub 2016 Sep 26. No abstract available.

PMID:
27689528
36.

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

Maggi M, Wu FC, Jones TH, Jackson G, Behre HM, Hackett G, Martin-Morales A, Balercia G, Dobs AS, Arver ST, Maggio M, Cunningham GR, Isidori AM, Quinton R, Wheaton OA, Siami FS, Rosen RC; RHYME Investigators.

Int J Clin Pract. 2016 Oct;70(10):843-852. doi: 10.1111/ijcp.12876.

PMID:
27774779
37.

Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Isidori AM, Venneri MA, Fiore D.

J Endocrinol Invest. 2016 Nov;39(11):1235-1246. Epub 2016 Jun 25. Review.

PMID:
27344309
38.

Contralateral interlaminar approach for intraforaminal lumbar degenerative disease with special emphasis on L5-S1 level: A technical note.

Zekaj E, Menghetti C, Saleh C, Isidori A, Bona AR, Aimar E, Servello D.

Surg Neurol Int. 2016 Sep 21;7:88. eCollection 2016.

39.

Multiparametric ultrasonography and ultrasound elastography in the differentiation of parathyroid lesions from ectopic thyroid lesions or lymphadenopathies.

Isidori AM, Cantisani V, Giannetta E, Diacinti D, David E, Forte V, Elia D, De Vito C, Sbardella E, Gianfrilli D, Monteleone F, Pepe J, Minisola S, Ascenti G, D'Andrea V, Catalano C, D'Ambrosio F.

Endocrine. 2017 Aug;57(2):335-343. doi: 10.1007/s12020-016-1116-1. Epub 2016 Oct 5.

PMID:
27709473
40.

Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays.

Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, Jafar-Mohammadi B, Grossman AB.

Clin Endocrinol (Oxf). 2017 Feb;86(2):177-184. doi: 10.1111/cen.13232. Epub 2016 Oct 3.

PMID:
27616279
41.

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.

Iurlo A, Nobili A, Latagliata R, Bucelli C, Castagnetti F, Breccia M, Abruzzese E, Cattaneo D, Fava C, Ferrero D, Gozzini A, Bonifacio M, Tiribelli M, Pregno P, Stagno F, Vigneri P, Annunziata M, Cavazzini F, Binotto G, Mansueto G, Russo S, Falzetti F, Montefusco E, Gugliotta G, Storti S, D'Addosio AM, Scaffidi L, Cortesi L, Cedrone M, Rossi AR, Avanzini P, Mauro E, Spadea A, Celesti F, Giglio G, Isidori A, Crugnola M, Calistri E, Sorà F, Rege-Cambrin G, Sica S, Luciano L, Galimberti S, Orlandi EM, Bocchia M, Tettamanti M, Alimena G, Saglio G, Rosti G, Mannucci PM, Cortelezzi A.

Oncotarget. 2016 Nov 29;7(48):80083-80090. doi: 10.18632/oncotarget.11657.

42.

Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure.

Barbagallo F, Xu B, Reddy GR, West T, Wang Q, Fu Q, Li M, Shi Q, Ginsburg KS, Ferrier W, Isidori AM, Naro F, Patel HH, Bossuyt J, Bers D, Xiang YK.

Circ Res. 2016 Sep 30;119(8):931-43. doi: 10.1161/CIRCRESAHA.116.308964. Epub 2016 Aug 30.

43.

Diagnostic value of qualitative and strain ratio elastography in the differential diagnosis of non-palpable testicular lesions.

Pozza C, Gianfrilli D, Fattorini G, Giannetta E, Barbagallo F, Nicolai E, Cristini C, Di Pierro GB, Franco G, Lenzi A, Sidhu PS, Cantisani V, Isidori AM.

Andrology. 2016 Nov;4(6):1193-1203. doi: 10.1111/andr.12260. Epub 2016 Aug 27.

44.

How Food Intakes Modify Testosterone Level.

Terrier JE, Isidori AM.

J Sex Med. 2016 Sep;13(9):1292-1296. doi: 10.1016/j.jsxm.2016.07.001. No abstract available.

PMID:
27555502
45.

Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury.

Di Siena S, Gimmelli R, Nori SL, Barbagallo F, Campolo F, Dolci S, Rossi P, Venneri MA, Giannetta E, Gianfrilli D, Feigenbaum L, Lenzi A, Naro F, Cianflone E, Mancuso T, Torella D, Isidori AM, Pellegrini M.

Cell Death Dis. 2016 Jul 28;7(7):e2317. doi: 10.1038/cddis.2016.205.

46.

Sonographic imaging of extra-testicular focal lesions: comparison of grey-scale, colour Doppler and contrast-enhanced ultrasound.

Rafailidis V, Robbie H, Konstantatou E, Huang DY, Deganello A, Sellars ME, Cantisani V, Isidori AM, Sidhu PS.

Ultrasound. 2016 Feb;24(1):23-33. doi: 10.1177/1742271X15626195. Epub 2016 Jan 8.

47.

β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes.

Cornacchione M, Pellegrini M, Fassina L, Mognaschi ME, Di Siena S, Gimmelli R, Ambrosino P, Soldovieri MV, Taglialatela M, Gianfrilli D, Isidori AM, Lenzi A, Naro F.

J Mol Cell Cardiol. 2016 Sep;98:146-58. doi: 10.1016/j.yjmcc.2016.07.004. Epub 2016 Jul 11.

PMID:
27418252
48.

Pituitary stalk thickening: the role of an innovative MRI imaging analysis which may assist in determining clinical management.

Sbardella E, Joseph RN, Jafar-Mohammadi B, Isidori AM, Cudlip S, Grossman AB.

Eur J Endocrinol. 2016 Oct;175(4):255-63. doi: 10.1530/EJE-16-0455. Epub 2016 Jul 14.

49.

Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase.

Breccia M, Abruzzese E, Iurlo A, Gozzini A, Isidori A, Gangemi D, Pregno P, Alimena G.

Haematologica. 2016 Jun;101(6):e267-8. doi: 10.3324/haematol.2016.145623. Epub 2016 May 31. No abstract available.

50.

Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning.

Isidori A, Christofides A, Visani G.

Leuk Lymphoma. 2016 Nov;57(11):2499-509. doi: 10.1080/10428194.2016.1185785. Epub 2016 May 31. Review.

PMID:
27243412

Supplemental Content

Loading ...
Support Center